Walgreens Boots Alliance Declares Quarterly Dividend
April 25 2024 - 12:53PM
Business Wire
Walgreens Boots Alliance, Inc. (Nasdaq: WBA) today announced
that its board of directors has declared a quarterly dividend of 25
cents per share, unchanged from the previous quarter. The dividend
is payable on June 12, 2024, to stockholders of record as of May
21, 2024.
Walgreens Boots Alliance and its predecessor company, Walgreen
Co., have paid a dividend in 366 straight quarters (91 years).
About Walgreens Boots Alliance
Walgreens Boots Alliance (Nasdaq: WBA) is an integrated
healthcare, pharmacy and retail leader serving millions of
customers and patients every day, with a 170-year heritage of
caring for communities.
A trusted, global innovator in retail pharmacy with
approximately 12,500 locations across the U.S., Europe and Latin
America, WBA plays a critical role in the healthcare ecosystem. The
Company is reimagining local healthcare and well-being for all as
part of its purpose – to create more joyful lives through better
health. Through dispensing medicines, improving access to a wide
range of health services, providing high quality health and beauty
products and offering anytime, anywhere convenience across its
digital platforms, WBA is shaping the future of healthcare.
WBA employs more than 315,000 people and has a presence in eight
countries through its portfolio of consumer brands: Walgreens,
Boots, Duane Reade, the No7 Beauty Company and Benavides in Mexico.
Additionally, WBA has a portfolio of healthcare-focused investments
located in several countries, including China and the U.S.
The Company is proud of its contributions to healthy
communities, a healthy planet, an inclusive workplace and a
sustainable marketplace. WBA has been recognized for its commitment
to operating sustainably: the Company is an index component of the
Dow Jones Sustainability Indices (DJSI) and was named to the 100
Best Corporate Citizens 2022.
More Company information is available at
www.walgreensbootsalliance.com.
(WBA-DIV)
Cautionary Note Regarding Forward-Looking Statements: All
statements in this release that are not historical are
forward-looking statements made pursuant to the safe harbor
provisions of the Private Securities Litigation Reform Act of 1995,
including, without limitation, statements regarding capital
allocation, the anticipated effects on our long-term balance sheet
and cash position as a result of reducing our dividend, our
expectations to right-size costs, increase cash flow and invest in
sustainable growth initiatives in the pharmacy and healthcare
businesses, and our ability to balance capital allocation
priorities. These forward-looking statements are not guarantees of
future performance and involve risks, assumptions and
uncertainties, including the financial performance of our
consolidated subsidiaries in the U.S. Healthcare segment, as well
as those described in Item 1A (Risk Factors) of our Form 10-K for
the fiscal year ended August 31, 2023 and in other documents that
we file or furnish with the Securities and Exchange Commission.
Should one or more of these risks or uncertainties materialize, or
should underlying assumptions prove incorrect, actual results may
vary materially from those indicated or anticipated by such
forward-looking statements. These forward-looking statements speak
only as of the date they are made. We do not undertake, and
expressly disclaim, any duty or obligation to update publicly any
forward-looking statement after the date of this release, whether
as a result of new information, future events, changes in
assumptions or otherwise.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240425506255/en/
WBA Media Relations USA / Jim Cohn, media@wba.com
International, +44 (0)20 7980 8585
WBA Investor Relations Chris Deyo, +1 847 315 2922
Walgreens Boots Alliance (NASDAQ:WBA)
Historical Stock Chart
From May 2024 to Jun 2024
Walgreens Boots Alliance (NASDAQ:WBA)
Historical Stock Chart
From Jun 2023 to Jun 2024